FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783196716> ?p ?o ?g. }

• W2783196716 endingPage "410" @default.
• W2783196716 startingPage "406" @default.
• W2783196716 abstract "Nivolumab response rate is 40% in metastatic melanoma. Few studies have evaluated pre-treatment biomarkers predictive of response. The aim of this study was to identify potential peripheral blood biomarkers associated with survival in patients with advanced melanoma treated with nivolumab. All advanced melanoma cases treated with anti-programmed cell death protein 1 (anti-PD1) over a 3-year period in the Dermato-Oncology Department, Nantes, France were identified. For each case, 9 potential blood biomarkers were identified. Bivariate and multivariate analyses, adjusted for the American Joint Committee on Cancer (AJCC) classification stage, Eastern Cooperative Oncology Group (ECOG) performance status, lactate dehydrogenase (LDH) level and failure to respond to first-line therapy, were used to test the association between biomarkers and overall survival (primary outcome) or progression-free survival (secondary outcome). Increased monocyte count, leukocyte/lymphocyte ratio and neutrophil/lymphocyte ratio were significantly associated with decreased overall survival after bivariate and multivariate analyses. Increased monocyte count was also significantly associated with decreased progression-free survival. These blood variables are easily measured and could help to predict patient response before the introduction of anti-PD1 therapy." @default.
• W2783196716 created "2018-01-26" @default.
• W2783196716 creator A5001247907 @default.
• W2783196716 creator A5002644565 @default.
• W2783196716 creator A5026888403 @default.
• W2783196716 creator A5035899929 @default.
• W2783196716 creator A5043124214 @default.
• W2783196716 creator A5045260573 @default.
• W2783196716 creator A5062950383 @default.
• W2783196716 creator A5064458374 @default.
• W2783196716 creator A5068321790 @default.
• W2783196716 creator A5090133438 @default.
• W2783196716 date "2018-01-01" @default.
• W2783196716 modified "2023-10-17" @default.
• W2783196716 title "Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma" @default.
• W2783196716 cites W1870093969 @default.
• W2783196716 cites W1977632329 @default.
• W2783196716 cites W2100158834 @default.
• W2783196716 cites W2112121482 @default.
• W2783196716 cites W2117692326 @default.
• W2783196716 cites W2118863192 @default.
• W2783196716 cites W2128035403 @default.
• W2783196716 cites W2136859769 @default.
• W2783196716 cites W2270932386 @default.
• W2783196716 cites W2282962877 @default.
• W2783196716 cites W2397854274 @default.
• W2783196716 cites W2529896336 @default.
• W2783196716 cites W2531648809 @default.
• W2783196716 cites W2582945086 @default.
• W2783196716 doi "https://doi.org/10.2340/00015555-2872" @default.
• W2783196716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29327065" @default.
• W2783196716 hasPublicationYear "2018" @default.
• W2783196716 type Work @default.
• W2783196716 sameAs 2783196716 @default.
• W2783196716 citedByCount "28" @default.
• W2783196716 countsByYear W27831967162018 @default.
• W2783196716 countsByYear W27831967162019 @default.
• W2783196716 countsByYear W27831967162020 @default.
• W2783196716 countsByYear W27831967162021 @default.
• W2783196716 countsByYear W27831967162022 @default.
• W2783196716 countsByYear W27831967162023 @default.
• W2783196716 crossrefType "journal-article" @default.
• W2783196716 hasAuthorship W2783196716A5001247907 @default.
• W2783196716 hasAuthorship W2783196716A5002644565 @default.
• W2783196716 hasAuthorship W2783196716A5026888403 @default.
• W2783196716 hasAuthorship W2783196716A5035899929 @default.
• W2783196716 hasAuthorship W2783196716A5043124214 @default.
• W2783196716 hasAuthorship W2783196716A5045260573 @default.
• W2783196716 hasAuthorship W2783196716A5062950383 @default.
• W2783196716 hasAuthorship W2783196716A5064458374 @default.
• W2783196716 hasAuthorship W2783196716A5068321790 @default.
• W2783196716 hasAuthorship W2783196716A5090133438 @default.
• W2783196716 hasBestOaLocation W27831967161 @default.
• W2783196716 hasConcept C121608353 @default.
• W2783196716 hasConcept C126322002 @default.
• W2783196716 hasConcept C143998085 @default.
• W2783196716 hasConcept C181199279 @default.
• W2783196716 hasConcept C2777318727 @default.
• W2783196716 hasConcept C2777658100 @default.
• W2783196716 hasConcept C2777701055 @default.
• W2783196716 hasConcept C2777761686 @default.
• W2783196716 hasConcept C2778963024 @default.
• W2783196716 hasConcept C2780030458 @default.
• W2783196716 hasConcept C2780739268 @default.
• W2783196716 hasConcept C3019894029 @default.
• W2783196716 hasConcept C38180746 @default.
• W2783196716 hasConcept C502942594 @default.
• W2783196716 hasConcept C55493867 @default.
• W2783196716 hasConcept C71924100 @default.
• W2783196716 hasConcept C86803240 @default.
• W2783196716 hasConceptScore W2783196716C121608353 @default.
• W2783196716 hasConceptScore W2783196716C126322002 @default.
• W2783196716 hasConceptScore W2783196716C143998085 @default.
• W2783196716 hasConceptScore W2783196716C181199279 @default.
• W2783196716 hasConceptScore W2783196716C2777318727 @default.
• W2783196716 hasConceptScore W2783196716C2777658100 @default.
• W2783196716 hasConceptScore W2783196716C2777701055 @default.
• W2783196716 hasConceptScore W2783196716C2777761686 @default.
• W2783196716 hasConceptScore W2783196716C2778963024 @default.
• W2783196716 hasConceptScore W2783196716C2780030458 @default.
• W2783196716 hasConceptScore W2783196716C2780739268 @default.
• W2783196716 hasConceptScore W2783196716C3019894029 @default.
• W2783196716 hasConceptScore W2783196716C38180746 @default.
• W2783196716 hasConceptScore W2783196716C502942594 @default.
• W2783196716 hasConceptScore W2783196716C55493867 @default.
• W2783196716 hasConceptScore W2783196716C71924100 @default.
• W2783196716 hasConceptScore W2783196716C86803240 @default.
• W2783196716 hasIssue "4" @default.
• W2783196716 hasLocation W27831967161 @default.
• W2783196716 hasLocation W27831967162 @default.
• W2783196716 hasLocation W27831967163 @default.
• W2783196716 hasLocation W27831967164 @default.
• W2783196716 hasLocation W27831967165 @default.
• W2783196716 hasOpenAccess W2783196716 @default.
• W2783196716 hasPrimaryLocation W27831967161 @default.
• W2783196716 hasRelatedWork W2783196716 @default.
• W2783196716 hasRelatedWork W2792066576 @default.
• W2783196716 hasRelatedWork W2892348505 @default.

• next